Ablynx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Ablynx and buy or sell other stocks, ETFs, and their options commission-free!About ABLX
Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology.
CEOGeert Deschamps
CEOGeert Deschamps
Employees—
Employees—
HeadquartersGhent, Flemish Region
HeadquartersGhent, Flemish Region
Founded2001
Founded2001
Employees—
Employees—
ABLX Key Statistics
Market cap3.95B
Market cap3.95B
Price-Earnings ratio-26.12
Price-Earnings ratio-26.12
Dividend yield—
Dividend yield—
Average volume3.44K
Average volume3.44K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$55.29
52 Week high$55.29
52 Week low$17.75
52 Week low$17.75
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.